ProfileGDS5822 / ILMN_2614788
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 82% 87% 85% 81% 83% 86% 85% 85% 78% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 1175.882
GSM1276600PDAC Late Ablation Control 2355.387
GSM1276601PDAC Late Ablation Control 3320.685
GSM1276602PDAC Late Ablation 1161.481
GSM1276603PDAC Late Ablation 2216.783
GSM1276604PDAC Late Ablation 3329.586
GSM1303940PDAC Late Ablation_anti-CTLA4 124385
GSM1303941PDAC Late Ablation_anti-CTLA4 2327.585
GSM1303942PDAC Late Ablation_anti-CTLA4 3154.278